Overview

Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

Status:
Completed
Trial end date:
2019-02-19
Target enrollment:
Participant gender:
Summary
Quantify the effect of a probe CYP3A4 inducer (Rifampicin) on the pharmacokinetics of levonorgestrel, norethindrone, desogestrel, dienogest, drospirenone,estradiol and midazolam
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Desogestrel
Dienogest
Drospirenone
Drospirenone and ethinyl estradiol combination
Ethinyl Estradiol
Levonorgestrel
Midazolam
Norethindrone
Norethindrone Acetate
Progestins
Rifampin